七彩化學(300758.SZ):近日收到賠償款共計2971.94萬元
格隆匯6月2日丨七彩化學(300758.SZ)公佈,公司於近日收到了中國人民財產保險股份有限公司遼寧省分公司賠償款,關於公司過火事故相關情況請見公司2019年6月24日、2019年7月19日、2020年1月17日、2020年9月24日、2021年4月23日披露的相關公吿。
根據遼寧省高級人民法院出具的《民事判決書》(2021)遼民終249號,公司於近日收到了中國人民財產保險股份有限公司遼寧省分公司賠償款共計人民幣29,719,406.21元;以上賠償款衝減其他應收款16,956,366.04元後,餘額計入當期損益。
此次收到的賠償款,不會對公司的生產經營產生重大影響。敬請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.